Recommended erythropoietin-stimulating agent dosing changes for anemia care in adults undergoing hemodialysis led to lower erythropoietin-stimulating agent use and lower hemoglobin levels.
Medicare policies are associated with reductions in the share of patients with an Alzheimer disease and related dementias code receiving hospice care.
Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week.
The U.S. Food and Drug Administration may soon curtail the use of 2 monoclonal antibody treatments that do not appear to work against the highly contagious omicron variant.
Researchers conducted a study that compared voter turnout between physicians and the general population for US elections held between 2000 and 2020.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
To assess whether states and territories adhered to these FSMB recommendations, authors obtained copies of initial license medical applications from 50 US states, the District of Columbia, Guam, the Northern Mariana Islands, and the US Virgin Islands.
Cohort study data from 2018 to 2019 suggest poor compliance with the US Food and Drug Administration reporting requirements for clinical trial sponsors.
A new study demonstrates the efficacy of a structured physician compensation model in achieving equitable pay for all employees, although the underrepresentation of women in leadership positions and the higher-paying specialties warrants further investigation.
A new bill aimed specifically at limiting medical liability was passed by Congress on March 1, 2017.
